| http://www.w3.org/ns/prov#value | - rmance of designed product enhancements, the Company's ability to develop and commercialize technologies and products, particularly new technologies such as noninvasive prenatal diagnostics, laboratory developed tests, and genetic analysis platforms, the Company's financial position, the Company's ability to '/>/>SOURCE Sequenom, Inc.Copyright??2012 PR Newswire.All rights reserved0GOODPage: 1 2 3
|
